|
|
Article: The American National Red Cross Affirms Its Ongoing Support of Joint Projects with ProMetic.
- Article from:
- PR Newswire
- Article date:
- March 1, 2005
CopyrightCOPYRIGHT 2005 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
The American National Red Cross (Red Cross) and ProMetic Life Sciences Inc. (TSX: PLI.SV) confirmed today that their joint projects are not being materially affected by the announced plasma supply transaction between the Red Cross and Baxter Healthcare Corporation (Baxter).
"The Red Cross will continue to work with ProMetic to build the value of our joint projects" said David Hammond, Executive Director, Research and Development, Plasma Derivatives, Red Cross. "The scientists directly involved in these projects are dedicated to advancing our joint programs according to our established plans."
There has been an ongoing strategic review of all Lines of ...